LEON successfully completes development of its innovative reactor for more efficient production of lipid nanoparticles
LEON achieved superior accuracy in development of its proprietary reactor, facilitating exceptional inter-device reproducibility of particle size and…
Interview: Unleashing the power of LNP encapsulation
Very interesting interview with our CFO, Christian Nafe in the latest winter edition of European Biotechnology Magazine. READ MORE
Harro Höfliger and LEON collaborate to bring the innovative NANOus LNP-encapsulation device to market
leon-nanodrugs GmbH and Harro Höfliger, announce today their collaboration on a manufacturing device to encapsulate mRNAs or active pharmaceutical…
Impact of Mixing Technologies on Transfection Performance in vivo
In cooperation with the team from EVOTEC, LEON performed a study on impact of mixing technologies on transfection performance in vivo. READ MORE
Comparison of different turbulent mixing technologies
We love to share our key findings. In this study our expert Julian Vogler - Lead Scientist Nanotechnology, compared different turbulent mixing…
MUNICH (Germany), 10th June, 2021 – leon-nanodrugs GmbH (‘LEON’), the Munich based nanotechnology company, has announced today the appointment…
leon-nanodrugs GmbH strengthens Supervisory Board with appointment of Dr Robert Becker
Dr Becker brings more than 35 years of pharmaceutical industry experience to the leon-nanodrugs offer leon-nanodrugs GmbH (‘LEON’), the Munich based…
Learnings from a career with its beginnings in lockdown
There are times in life when things just don’t go according to plan. Earlier this year, when I heard that I had achieved the first step in my career…
Here, Andrea Cusack, Chief Executive Officer, leon, discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in…